Buformin-d9 (hydrochloride)
Buformin-d9 (hydrochloride) is the deuterium labeled Buformin. Buformin (1-Butylbiguanide), a potent AMPK activator, acts as an orally active biguanide antidiabetic agent. Buformin decreases hepatic gluconeogenesis and lowers blood glucose production in vivo. Buformin also has anti-cancer activities and is applied in cancer study (such as, cervical cancer and breast cancer, et al) [1].
Product Specifications
Product Name Alternative
1-Butylbiguanide-d9 (hydrochloride)
UNSPSC
12352211
Target
AMPK; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Epigenetics; Others; PI3K/Akt/mTOR
Field of Research
Cancer; Metabolic Disease
Solubility
10 mM in DMSO
Smiles
N=C(N)NC(NC([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=N.[H]Cl
Molecular Formula
C6H7D9ClN5
Molecular Weight
202.73
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
p-Nitrophenyl 2-Acetamido-2-deoxy-Alpha-D-galactopyranoside
